Alpha 2-antiplasmin
Alpha-2-antiplasmin is a serine protease inhibitor (serpin) that plays a crucial role in the regulation of the fibrinolytic system. It is primarily responsible for inhibiting plasmin, the enzyme that degrades fibrin clots. By controlling plasmin activity, alpha-2-antiplasmin helps maintain the balance between clot formation and clot dissolution, which is essential for normal hemostasis.
Structure and Function[edit | edit source]
Alpha-2-antiplasmin is a glycoprotein synthesized mainly in the liver. It circulates in the blood plasma and is composed of a single polypeptide chain. The primary function of alpha-2-antiplasmin is to inhibit plasmin, thereby preventing excessive fibrinolysis and ensuring that blood clots are stable enough to prevent bleeding.
The interaction between alpha-2-antiplasmin and plasmin is a key component of the fibrinolytic system. When a blood clot forms, plasminogen is converted to plasmin, which then degrades fibrin. Alpha-2-antiplasmin binds to plasmin, inhibiting its activity and thus regulating the breakdown of fibrin clots.
Role in Fibrinolysis[edit | edit source]
Fibrinolysis is the process by which fibrin clots are broken down in the body. This process is essential for wound healing and the prevention of thrombosis. Alpha-2-antiplasmin is a major inhibitor of fibrinolysis, acting by binding to plasmin and preventing it from degrading fibrin.
In the fibrinolytic pathway, plasminogen is activated to plasmin by tissue plasminogen activator (tPA) or urokinase. Plasmin then degrades fibrin into soluble fragments. Alpha-2-antiplasmin rapidly inhibits free plasmin, ensuring that fibrinolysis is localized to the site of the clot and does not lead to systemic bleeding.
Clinical Significance[edit | edit source]
Deficiencies or dysfunctions in alpha-2-antiplasmin can lead to bleeding disorders due to excessive fibrinolysis. Conversely, elevated levels of alpha-2-antiplasmin can contribute to thrombotic conditions by preventing the normal breakdown of clots.
Alpha-2-antiplasmin levels can be measured in the laboratory to assess fibrinolytic activity and diagnose bleeding disorders. Therapeutic modulation of alpha-2-antiplasmin activity is a potential strategy for managing conditions such as deep vein thrombosis and pulmonary embolism.
Related Pages[edit | edit source]
Alpha_2-antiplasmin[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD